Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies.

MLA

Vanderheiden, Abigail, et al. “Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies.” Current Protocols in Immunology, vol. 131, no. 1, Dec. 2020, p. e116. EBSCOhost, https://doi.org/10.1002/cpim.116.

APA

Vanderheiden, A., Edara, V. V., Floyd, K., Kauffman, R. C., Mantus, G., Anderson, E., Rouphael, N., Edupuganti, S., Shi, P.-Y., Menachery, V. D., Wrammert, J., & Suthar, M. S. (2020). Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies. Current Protocols in Immunology, 131(1), e116. https://doi.org/10.1002/cpim.116

Chicago

Vanderheiden, Abigail, Venkata Viswanadh Edara, Katharine Floyd, Robert C Kauffman, Grace Mantus, Evan Anderson, Nadine Rouphael, et al. 2020. “Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies.” Current Protocols in Immunology 131 (1): e116. doi:10.1002/cpim.116.